Table 1 |
|||||||||||||
|
Clinical and histological characteristics of ACD patients. |
|||||||||||||
|
Patients |
Sex |
Age |
Skin Patch Test Reactivity |
Macroscopic response* |
Histologic grade** |
||||||||
|
|
|
|
|||||||||||
|
Positive Antigen |
Negative Antigen |
Positive Antigen |
Negative Antigen |
Positive Antigen |
Negative Antigen |
||||||||
|
|
|||||||||||||
|
2 h |
10 h |
48 h |
48 h |
2 h |
10 h |
48 h |
48 h |
||||||
|
|
|||||||||||||
|
MO |
F |
58 |
Neomicine |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+/- |
+++ |
+/- |
|
|
MR |
M |
65 |
Thimerosal |
Antraquinone |
- |
- |
+++ |
- |
+ |
++ |
+++ |
+/- |
|
|
AS |
F |
46 |
Neomicine |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+ |
++ |
+/- |
|
|
ER |
M |
49 |
p-phenylenediamine |
Antraquinone |
- |
- |
+++ |
- |
+/- |
++ |
+++ |
+/- |
|
|
IL |
F |
49 |
Quarternium 15 |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+ |
+ |
+/- |
|
|
AC |
F |
49 |
Quinolina mix |
Antraquinone |
- |
- |
+++ |
- |
+/- |
++ |
+++ |
+/- |
|
|
LG |
F |
46 |
Balsamo Peru |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+ |
+++ |
+/- |
|
|
MG |
F |
29 |
Nickel |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+ |
++ |
+/- |
|
|
SA |
F |
64 |
Irgasan |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+ |
++ |
+/- |
|
|
TV |
F |
23 |
Nickel |
Antraquinone |
- |
- |
+++ |
- |
+/- |
+ |
+++ |
+/- |
|
|
|
|||||||||||||
|
* Skin erythema, papule and vesicle: – (absent); + (mild); ++ (moderate); +++ (intense). ** Mononuclear cell infiltration: +/- (scattered); + (mild); ++ (moderate); +++ (intense). See Material and Methods. |
|||||||||||||
|
Martín et al. BMC Dermatology 2002 2:9 doi:10.1186/1471-5945-2-9 |
|||||||||||||
